Vascular Grafts - Medical Devices Pipeline Assessment, 2017

  • ID: 4375964
  • Report
  • 86 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • 3S BioMedical, Inc.
  • Cardiojustable LLC
  • Eqalix Inc
  • Healionics Corporation
  • Northwestern University
  • Universidad de Los Andes
  • MORE
Vascular Grafts - Medical Devices Pipeline Assessment, 2017

Summary

The author's Medical Devices sector report, “Vascular Grafts - Medical Devices Pipeline Assessment, 2017" provides an overview of Vascular Grafts currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Vascular Grafts pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Vascular Grafts under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Vascular Grafts and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Vascular Grafts under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 3S BioMedical, Inc.
  • Cardiojustable LLC
  • Eqalix Inc
  • Healionics Corporation
  • Northwestern University
  • Universidad de Los Andes
  • MORE
1 Table of Contents
2 Introduction
2.1 Vascular Grafts Overview
3 Products under Development
3.1 Vascular Grafts - Pipeline Products by Stage of Development
3.2 Vascular Grafts - Pipeline Products by Segment
3.3 Vascular Grafts - Pipeline Products by Territory
3.4 Vascular Grafts - Pipeline Products by Regulatory Path
3.5 Vascular Grafts - Pipeline Products by Estimated Approval Date
3.6 Vascular Grafts - Ongoing Clinical Trials
4 Vascular Grafts - Pipeline Products under Development by Companies
4.1 Vascular Grafts Companies - Pipeline Products by Stage of Development
4.2 Vascular Grafts - Pipeline Products by Stage of Development
5 Vascular Grafts Companies and Product Overview
5.1 3S BioMedical, Inc. Company Overview
5.1.1 3S BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.2 Ariste Medical LLC Company Overview
5.2.1 Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.3 C. R. Bard Inc Company Overview
5.3.1 C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Cardiojustable LLC (Inactive) Company Overview
5.4.1 Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.5 Colorado Therapeutics, LLC Company Overview
5.5.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.6 CryoLife Inc Company Overview
5.6.1 CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 DSM Biomedical BV Company Overview
5.7.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview
5.8 Eqalix Inc Company Overview
5.8.1 Eqalix Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 FIT Biotech Oy Company Overview
5.9.1 FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview
5.10 Gel-Del Technologies, Inc. Company Overview
5.10.1 Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.11 Graftworx, LLC Company Overview
5.11.1 Graftworx, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.12 Healionics Corporation Company Overview
5.12.1 Healionics Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.13 Humacyte Inc Company Overview
5.13.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Innovia LLC Company Overview
5.14.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
5.15 Northwestern University Company Overview
5.15.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
5.16 NuVascular Technologies Inc Company Overview
5.16.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.17 PetVivo Holdings Inc Company Overview
5.17.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 RegenaGraft Company Overview
5.18.1 RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview
5.19 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.19.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
5.20 SurgaColl Technologies Ltd Company Overview
5.20.1 SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.21 Universidad de Los Andes Company Overview
5.21.1 Universidad de Los Andes Pipeline Products & Ongoing Clinical Trials Overview
5.22 University of Louisville Company Overview
5.22.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview
5.23 Vascutek Ltd Company Overview
5.23.1 Vascutek Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.24 VesselTek BioMedical LLC Company Overview
5.24.1 VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.25 VESSL Therapeutics Ltd Company Overview
5.25.1 VESSL Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.26 Xeltis AG Company Overview
5.26.1 Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview
6 Vascular Grafts- Recent Developments
6.1 Jul 27, 2017: LeMaitre Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%)
6.2 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017
6.3 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017
6.4 Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results
6.5 Jul 07, 2017: MPSC New COO Glendy Wang on Board
6.6 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day
6.7 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017
6.8 Apr 27, 2017: Fit Biotech: Appointments in Fit Biotech's Management
6.9 Apr 26, 2017: LeMaitre Q1 2017 Record Sales $24.1 mm (+19%), Net Income $3.2 mm (+49%)
6.10 Apr 26, 2017: CryoLife Reports First Quarter 2017 Financial Results
6.11 Apr 23, 2017: Bard Announces First Quarter Results
6.12 Apr 03, 2017: Retrospective Study Confirms Bovine Carotid Artery Biologic Graft Outperforms Expanded Polytetrafluoroethylene for Hemodialysis Access
6.13 Mar 30, 2017: FIT Biotech: Appointment to FIT Biotech’s Management Team
6.14 Mar 30, 2017: MPSC Announces 2016 Annual Results
6.15 Feb 21, 2017: LeMaitre Q4 2016 Record Sales $23.3 mm (+14%), Op. Income $3.9 mm (+27%)
6.16 Feb 15, 2017: CryoLife Reports Fourth Quarter and Full Year 2016 Financial Results
6.17 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016
6.18 Jan 26, 2017: Bard Announces Fourth Quarter Results
6.19 Jan 16, 2017: SurgaColl Technologies: Board Announcement - Appointment of CEO
6.20 Dec 29, 2016: Humacyte Commences U.S. Phase II Arterial Bypass Clinical Trial
6.21 Nov 03, 2016: DSM Q3 2016 Results
6.22 Nov 01, 2016: Xeltis Announces Multidisciplinary Scientific Advisory Board of Global Leading Experts
6.23 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016
6.24 Oct 26, 2016: CryoLife Reports Third Quarter 2016 Financial Results
6.25 Oct 26, 2016: LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%)
6.26 Oct 25, 2016: James W. Bullock Joins CryoLife Board of Directors
6.27 Oct 25, 2016: Bard Announces Third Quarter Results
6.28 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer
6.29 Sep 16, 2016: Federal Circuit Court of Appeals upholds LifeNet Health's $34.7 million patent victory
6.30 Sep 14, 2016: Fit Biotech Oy’s Half-year Financial Report January 1-June 30, 2016
6.31 Sep 06, 2016: CryoLife Appoints James McDermid as Chief Human Resources Officer
6.32 Aug 30, 2016: MPSC Announces 2016 Interim Results
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Vascular Grafts - Pipeline Products by Stage of Development
Table 2: Vascular Grafts - Pipeline Products by Segment
Table 3: Vascular Grafts - Pipeline Products by Territory
Table 4: Vascular Grafts - Pipeline Products by Regulatory Path
Table 5: Vascular Grafts - Pipeline Products by Estimated Approval Date
Table 6: Vascular Grafts - Ongoing Clinical Trials
Table 7: Vascular Grafts Companies - Pipeline Products by Stage of Development
Table 8: Vascular Grafts - Pipeline Products by Stage of Development
Table 9: 3S BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Resorpor AdvaMatrix Micro Small Vessel Graft - Product Status
Table 11: Resorpor AdvaMatrix Micro Small Vessel Graft - Product Description
Table 12: Resorpor AdvaMatrixrPro Vessel Graft - Product Status
Table 13: Resorpor AdvaMatrixrPro Vessel Graft - Product Description
Table 14: Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Drug Eluting Vascular Graft - Product Status
Table 16: Drug Eluting Vascular Graft - Product Description
Table 17: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Covera Vascular Covered Stent Graft - Product Status
Table 19: Covera Vascular Covered Stent Graft - Product Description
Table 20: Lifestream Stent Graft - Product Status
Table 21: Lifestream Stent Graft - Product Description
Table 22: C. R. Bard Inc - Ongoing Clinical Trials Overview
Table 23: Lifestream Stent Graft - A Prospective, Multi-center, Non-randomized, Single-arm Study of the Bard Lifestream Balloon Expandable Vascular Covered Stent in the Treatment of Iliac Artery Occlusive Disease: BOLSTER
Table 24: Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Adjustable SPA Shunt - Product Status
Table 26: Adjustable SPA Shunt - Product Description
Table 27: Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Xenograft Implant - Peripheral Vascular Disease - Product Status
Table 29: Xenograft Implant - Peripheral Vascular Disease - Product Description
Table 30: CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Synergraft Xenograft Vascular Graft - Product Status
Table 32: Synergraft Xenograft Vascular Graft - Product Description
Table 33: DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Small Diameter Vascular Graft - Product Status
Table 35: Small Diameter Vascular Graft - Product Description
Table 36: Eqalix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 37: CardioVessel - Product Status
Table 38: CardioVessel - Product Description
Table 39: LCL Graft - Product Status
Table 40: LCL Graft - Product Description
Table 41: FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview
Table 42: GTU X-Graft - Product Status
Table 43: GTU X-Graft - Product Description
Table 44: GTU X2-Graft - Product Status
Table 45: GTU X2-Graft - Product Description
Table 46: Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 47: VasoGraft - Product Status
Table 48: VasoGraft - Product Description
Table 49: Graftworx, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Smart Graft - Product Status
Table 51: Smart Graft - Product Description
Table 52: Healionics Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 53: STARgraft - Vascular Reconstruction - Product Status
Table 54: STARgraft - Vascular Reconstruction - Product Description
Table 55: Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 56: HAV Graft - Vascular Trauma - Product Status
Table 57: HAV Graft - Vascular Trauma - Product Description
Table 58: HUMACYL - Peripheral Artery Disease - Product Status
Table 59: HUMACYL - Peripheral Artery Disease - Product Description
Table 60: Humacyte Inc - Ongoing Clinical Trials Overview
Table 61: HUMACYL - Peripheral Artery Disease - A Phase 2 Study for the Evaluation of Safety and Efficacy of Humacytes Human Acellular Vessel for Use as a Vascular Bypass or Interposition Vessel in Patients with Limb-threatening Peripheral Arterial Trauma
Table 62: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 63: 4mm Vascular Graft - Product Status
Table 64: 4mm Vascular Graft - Product Description
Table 65: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
Table 66: ePTFE Graft - Peripheral Arterial Disease - Product Status
Table 67: ePTFE Graft - Peripheral Arterial Disease - Product Description
Table 68: NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 69: BioFunc - APC Vascular Graft - Product Status
Table 70: BioFunc - APC Vascular Graft - Product Description
Table 71: PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 72: Peripheral Vascular Graft - Product Status
Table 73: Peripheral Vascular Graft - Product Description
Table 74: RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview
Table 75: RegenaVasc - Product Status
Table 76: RegenaVasc - Product Description
Table 77: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
Table 78: Enhanced Vascular Graft - Product Status
Table 79: Enhanced Vascular Graft - Product Description
Table 80: SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 81: CardioColl - Product Status
Table 82: CardioColl - Product Description
Table 83: Universidad de Los Andes Pipeline Products & Ongoing Clinical Trials Overview
Table 84: SiSgraft - Product Status
Table 85: SiSgraft - Product Description
Table 86: University of Louisville Pipeline Products & Ongoing Clinical Trials Overview
Table 87: Vascular Graft System - Product Status
Table 88: Vascular Graft System - Product Description
Table 89: Vascutek Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 90: Triplex Advanced Vascular Graft - Product Status
Table 91: Triplex Advanced Vascular Graft - Product Description
Table 92: VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 93: VTek Graft - Product Status
Table 94: VTek Graft - Product Description
Table 95: VTek-RA Wrap - Product Status
Table 96: VTek-RA Wrap - Product Description
Table 97: VESSL Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 98: MultiGeneGraft - Product Status
Table 99: MultiGeneGraft - Product Description
Table 100: Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview
Table 101: Endogenous Tissue Growth Implant - Product Status
Table 102: Endogenous Tissue Growth Implant - Product Description
Table 103: Glossary

List of Figures
Figure 1: Vascular Grafts - Pipeline Products by Stage of Development
Figure 2: Vascular Grafts - Pipeline Products by Segment
Figure 3: Vascular Grafts - Pipeline Products by Territory
Figure 4: Vascular Grafts - Pipeline Products by Regulatory Path
Figure 5: Vascular Grafts - Pipeline Products by Estimated Approval Date
Figure 6: Vascular Grafts - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • 3S BioMedical, Inc.
  • Ariste Medical LLC
  • C. R. Bard Inc
  • Cardiojustable LLC
  • Colorado Therapeutics, LLC
  • CryoLife Inc
  • DSM Biomedical BV
  • Eqalix Inc
  • FIT Biotech Oy
  • Gel-Del Technologies, Inc.
  • Graftworx, LLC
  • Healionics Corporation
  • Humacyte Inc
  • Innovia LLC
  • Northwestern University
  • NuVascular Technologies Inc
  • PetVivo Holdings Inc
  • RegenaGraft
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • SurgaColl Technologies Ltd
  • Universidad de Los Andes
  • University of Louisville
  • Vascutek Ltd
  • VesselTek BioMedical LLC
  • VESSL Therapeutics Ltd
  • Xeltis AG
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll